• Isochlorogenic Acid A Disrupts the HBV Life Cycle

  2026-09-10

  The reference study shows that isochlorogenic acid A suppresses hepatitis B virus replication through coordinated effects on HO-1-mediated reactive oxygen species regulation, viral gene expression, cccDNA-associated signals, capsid formation, and envelopment. Its value lies in connecting redox biology with several distinct stages of HBV morphogenesis, while also defining experimental readouts for testing this mechanism.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-09-09

  This study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA. Its integrated clinical, multi-omic, biochemical, and animal-model evidence defines an RCN2–UBR5–PPP2CA–PI3K-AKT axis that may help explain treatment failure in advanced ESCC.

• SM-102 for mRNA Delivery: Practical LNP Guide

  2026-09-09

  SM-102 offers a practical ionizable-lipid starting point for lipid nanoparticle workflows spanning mRNA vaccine development, cell assays, and formulation screening. This guide connects product handling, reproducible mixing, data-driven comparison, and troubleshooting so researchers can separate lipid performance from process variability.

• Lipo3K Transfection Reagent for GBM Assays

  2026-09-08

  Use Lipo3K Transfection Reagent to build efficient PXDN knockdown, LDHA rescue, and DNA–siRNA co-transfection workflows in glioblastoma models. Its low-toxicity profile, enhancer option for plasmids, and compatibility with serum-containing media help connect mechanistic gene studies with reproducible metabolic assays.

• HyperScribe All in One mRNA Synthesis Kit Plus 1 Guide

  2026-09-08

  Build capped, modified, and polyadenylated mRNA in one coordinated workflow for translation studies, RNA vaccine development, and RNA interference (RNAi) experiments. This guide explains how ARCA capping, 5mCTP, ψUTP, DNase treatment, and poly(A) tailing work together, with practical controls and troubleshooting for reproducible results.

• PPP1R3G/PP1γ Activates RIPK1 Cell Death

  2026-09-07

  Du et al. identify PPP1R3G as the regulatory subunit that recruits PP1γ to dephosphorylate and activate RIPK1, thereby enabling RIPK1-dependent apoptosis and type I necroptosis. The study combines sensitized CRISPR screening, genetic rescue, phosphosite bypass, and mouse experiments to connect RIPK1 regulation with TNF-driven inflammatory pathology.

• CP-673451: A Precision Lens on PDGFR in Glioma

  2026-09-07

  CP-673451 offers a selective, mechanism-focused way to interrogate PDGFRα/β signaling, angiogenesis, and tumor biology. Combined with ATRX stratification and temozolomide-response analysis, it can help translational researchers distinguish target engagement from context-dependent therapeutic vulnerability.

• ML365 and NLRP3 Signaling in Aged-Mouse POCD

  2026-09-05

  A 2024 Brain Research study reports that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy, coinciding with lower hippocampal NLRP3 inflammasome signaling, less tissue injury, and reduced oxidative stress. The work is notable for linking K2P channel pharmacology with postoperative neuroinflammation, while its findings still require direct target-engagement and translational validation.

• RWJ 67657: From Blockade to Signal Reset

  2026-09-04

  RWJ 67657 (JNJ-3026582) is a selective p38α/β inhibitor for dissecting inflammatory signaling. This article connects its TNF-alpha activity with new structural insights into p38α dephosphorylation and shows how to design more informative assays.

• ARCA Cy5 EGFP mRNA: Delivery Assay Guide

  2026-09-04

  Track both mRNA entry and functional protein expression in the same mammalian-cell experiment. This guide shows how to use a Cy5-labeled, 5-methoxyuridine modified reporter to compare delivery systems, diagnose nonproductive uptake, and connect bench assays with mRNA-LNP development.

• WDR36, Glycolysis, and Human Trophectoderm Fate

  2026-09-03

  The reference study uses mouse embryos and human pluripotent stem cell-derived blastoids to show that WDR36 supports trophectoderm differentiation through glucose metabolism. Its combination of developmental phenotyping, transcriptomics, targeted metabolomics, and LDHA interaction analysis provides a mechanistic framework for studying early embryonic arrest and lineage specification.

• PD 0332991 (Palbociclib) HCl Research Guide

  2026-09-03

  PD 0332991, also called Palbociclib HCl, is a selective CDK4/6 inhibitor that produces Rb pathway inhibition and cell-cycle arrest in Rb-positive research models. The key interpretation rule is that reduced viability can reflect proliferative arrest, cell death, or both, so endpoint selection must match the experimental question.

• Palomid 529: Causal PI3K/Akt Assay Design

  2026-09-02

  Palomid 529 (P529) provides a useful pharmacological probe for testing how PI3K/Akt/mTOR signaling sustains metastasis, cisplatin resistance, and angiogenesis. This article translates the RCN2–PPP2CA–PI3K-AKT findings in ESCC into a rigorous, decision-oriented assay strategy.

• Apicidin: From HDAC Mechanism to Translation

  2026-09-02

  Apicidin is more than a potent histone deacetylase inhibitor: it is a translational probe connecting chromatin regulation, cancer biology, angiogenesis, and reproductive toxicology. This thought-leadership analysis examines how its HDAC3/HDAC6 activity can guide assay design while highlighting the limits of moving from preclinical efficacy to safety or clinical interpretation.

• Ferrostatins, Lipid Damage, and Cell Death

  2026-09-01

  Skouta and colleagues show that ferrostatin-1 suppresses ferroptosis by preventing oxidative damage to membrane lipids rather than by broadly eliminating cellular reactive oxygen species. Across Huntington’s disease, periventricular leukomalacia, and kidney-related models, the study links lipid peroxidation to diverse cell-death phenotypes and establishes a framework for designing improved ferrostatins.

8194 records 5/547 page Previous Next 12345 下5页 Last page